Spotlight
A selection of resources from across the Federation
Resource
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
This technical brief outlines key recommendations across several sexual and reproductive health service areas to promote access to inclusive care for transgender and gender diverse people.
Most Popular This Week
Resource
|
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
IPPF’s commitment to person-centred care is at the heart of its strategy, Come Together (2023–2028).
Resource
|
Sexual and gender-based violence services and programming overview brief
The International Planned Parenthood Federation (IPPF) is pleased to be share this sexual and gender-based violence services and programming overview document.
Resource
|
IPPF Storage Room poster
IPPF is pleased to be providing an important poster aimed at promoting safe and effective storage practices for medical supplies in your storage rooms.
Resource
|
IMAP Statement on the importance of ensuring abortion care after 13 weeks’ gestation
This statement was prepared by the International Medical Advisory Panel (IMAP) and approved in November 2024.
Resource
|
Youth-Led Digital Solutions to Advance CSE and Adolescent and Youth Friendly Services
Commonly dubbed “the digital generation”, young people are driving innovative digital solutions to lead critical conversations related to sexual and reproductive health, rights, and justice (SRHRJ)
Resource
|
2023 Annual Performance Report
Last year saw a relentless assault on human rights, leaving many feeling anxious and pessimistic about the prospects for people from all walks of life to come together.
Resource
|
IMAP Statement on Menopause
What is menopause? Menopause is a retrospective diagnosis: it is defined after a woman or person who can menstruate is amenorrheic for 12 months.
Resource
|
IMAP Statement on Person-centred Care for Sexually Transmitted Infections
Recognizing the significant global impact of sexually transmitted infections (STIs), this statement affirms IPPF’s commitment to people-centred STI care as a critical aspect of comprehensive sexual
Filter our resources by:
Resource
| 19 August 2024
IMAP Statement - Mpox
Mpox is a viral zoonotic disease which typically occurs in tropical areas in central and west Africa. From May 2022-July 2023, multiple cases of mpox were identified in non-endemic countries, and the World Health Organization declared the mpox outbreak a Public Health Emergency of International Concern. This marked the first time many mpox cases were reported concurrently in non-endemic and endemic countries in different geographical areas. During the outbreak, nearly 100,000 people were infected, primarily gay and bisexual men, and approximately 200 people died. This statement was prepared by Nathalie Kapp, Chief Medical Advisor with support from the International Medical Advisory Panel (IMAP) members: Arachu Castro, Michalina Drejza, Gail Knudson, Zozo Nene, Prof. Pascale Allotey, Janet Meyers, Professor Michael Mbizvo (Co-Chair), Chipo Gwanzura (Co-Chair), Paul D. Blumenthal, and Edmore Munongo. We thank the panel for their valuable and timely guidance and reviews offered during the development process.
Resource
| 19 August 2024
IMAP Statement - Mpox
Mpox is a viral zoonotic disease which typically occurs in tropical areas in central and west Africa. From May 2022-July 2023, multiple cases of mpox were identified in non-endemic countries, and the World Health Organization declared the mpox outbreak a Public Health Emergency of International Concern. This marked the first time many mpox cases were reported concurrently in non-endemic and endemic countries in different geographical areas. During the outbreak, nearly 100,000 people were infected, primarily gay and bisexual men, and approximately 200 people died. This statement was prepared by Nathalie Kapp, Chief Medical Advisor with support from the International Medical Advisory Panel (IMAP) members: Arachu Castro, Michalina Drejza, Gail Knudson, Zozo Nene, Prof. Pascale Allotey, Janet Meyers, Professor Michael Mbizvo (Co-Chair), Chipo Gwanzura (Co-Chair), Paul D. Blumenthal, and Edmore Munongo. We thank the panel for their valuable and timely guidance and reviews offered during the development process.
Resource
| 19 August 2024
IMAP Statement - Mpox
Mpox is a viral zoonotic disease which typically occurs in tropical areas in central and west Africa. From May 2022-July 2023, multiple cases of mpox were identified in non-endemic countries, and the World Health Organization declared the mpox outbreak a Public Health Emergency of International Concern. This marked the first time many mpox cases were reported concurrently in non-endemic and endemic countries in different geographical areas. During the outbreak, nearly 100,000 people were infected, primarily gay and bisexual men, and approximately 200 people died. This statement was prepared by Nathalie Kapp, Chief Medical Advisor with support from the International Medical Advisory Panel (IMAP) members: Arachu Castro, Michalina Drejza, Gail Knudson, Zozo Nene, Prof. Pascale Allotey, Janet Meyers, Professor Michael Mbizvo (Co-Chair), Chipo Gwanzura (Co-Chair), Paul D. Blumenthal, and Edmore Munongo. We thank the panel for their valuable and timely guidance and reviews offered during the development process.
Resource
| 19 August 2024
IMAP Statement - Mpox
Mpox is a viral zoonotic disease which typically occurs in tropical areas in central and west Africa. From May 2022-July 2023, multiple cases of mpox were identified in non-endemic countries, and the World Health Organization declared the mpox outbreak a Public Health Emergency of International Concern. This marked the first time many mpox cases were reported concurrently in non-endemic and endemic countries in different geographical areas. During the outbreak, nearly 100,000 people were infected, primarily gay and bisexual men, and approximately 200 people died. This statement was prepared by Nathalie Kapp, Chief Medical Advisor with support from the International Medical Advisory Panel (IMAP) members: Arachu Castro, Michalina Drejza, Gail Knudson, Zozo Nene, Prof. Pascale Allotey, Janet Meyers, Professor Michael Mbizvo (Co-Chair), Chipo Gwanzura (Co-Chair), Paul D. Blumenthal, and Edmore Munongo. We thank the panel for their valuable and timely guidance and reviews offered during the development process.
